- Home
- FLYE vs TRIB Comparison
FLYE vs TRIB Comparison
Compare FLYE & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYE
- TRIB
- Stock Information
- Founded
- FLYE 2018
- TRIB 1992
- Country
- FLYE United States
- TRIB Ireland
- Employees
- FLYE N/A
- TRIB N/A
- Industry
- FLYE Aerospace
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- FLYE Industrials
- TRIB Health Care
- Exchange
- FLYE Nasdaq
- TRIB Nasdaq
- Market Cap
- FLYE 15.4M
- TRIB 15.8M
- IPO Year
- FLYE 2024
- TRIB N/A
- Fundamental
- Price
- FLYE $0.58
- TRIB $1.48
- Analyst Decision
- FLYE
- TRIB
- Analyst Count
- FLYE 0
- TRIB 0
- Target Price
- FLYE N/A
- TRIB N/A
- AVG Volume (30 Days)
- FLYE 376.9K
- TRIB 166.9K
- Earning Date
- FLYE 11-26-2024
- TRIB 11-15-2024
- Dividend Yield
- FLYE N/A
- TRIB N/A
- EPS Growth
- FLYE 1.84
- TRIB N/A
- EPS
- FLYE 0.06
- TRIB N/A
- Revenue
- FLYE $32,236,745.00
- TRIB $58,652,000.00
- Revenue This Year
- FLYE N/A
- TRIB $17.64
- Revenue Next Year
- FLYE N/A
- TRIB $9.84
- P/E Ratio
- FLYE $10.39
- TRIB N/A
- Revenue Growth
- FLYE 36.51
- TRIB 8.60
- 52 Week Low
- FLYE $0.51
- TRIB $1.05
- 52 Week High
- FLYE $7.62
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- FLYE N/A
- TRIB 42.63
- Support Level
- FLYE N/A
- TRIB $1.49
- Resistance Level
- FLYE N/A
- TRIB $1.70
- Average True Range (ATR)
- FLYE 0.00
- TRIB 0.16
- MACD
- FLYE 0.00
- TRIB -0.03
- Stochastic Oscillator
- FLYE 0.00
- TRIB 5.56
About FLYE Fly-E Group Inc. Common Stock
Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.